Enter a Search String |
| Special character and space not allowed in the query term. Search string should be at least 2 characters long. |
Molecule Parameter List for Cdc20 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The statistics table lists the distribution of a molecule acting either as a substrate, product, enzyme or as a molecule within the network. The text color of a molecule is highlighted by color. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Statistics | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cdc20 participated as | Molecule | Sum total of | Enzyme | Substrate of an enzyme | Product of an enzyme | Substrate in Reaction | Product in Reaction |
| No. of occurrences | 1 | 0 | 4 | 1 | 1 | 1 | 0 |
Accession and Pathway Details |
| Accession Name | Accession No. | Accession Type | Pathway Link |
cycle | 85 | Network | Growth, CELLDIV, Rb_grp, IE_GRP, CycB_Grp, Cdc20_Grp, Cdh1_grp, E2F, CycA_Grp, CycE_grp, Early_Response_Genes, Delayed_Response_Genes, CycD_Grp |
| This is a fairly complete mass-action reimplementation of the Novak and Tyson mammalian cell cycle model. It is inexact on two counts. First, it replaces many rather abstracted equations with mass action and Michaelis-Menten forms of enzymes. Second, it does not handle the halving of cellular volume at the division point. Within these limitations, the model does most of what the original paper shows including oscillation of the relevant molecules. | |||
Cdc20 acting as a Molecule in Mammalian_cell_cycle Network
| Name | Accession Name | Pathway Name | Initial Conc. (uM) | Volume (fL) | Buffered |
| Cdc20 | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 0 | 200 | No |
Cdc20 acting as an Enzyme in Mammalian_cell_cycle Network
| Enzyme Molecule / Enzyme Activity | Accession Name | Pathway Name | Km (uM) | kcat (s^-1) | Ratio | Enzyme Type | Reagents | |
| 1 | Cdc20 / k2_prime_prime | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 99.9992 | 100 | 4 | explicit E-S complex | Substrate CycB Product degraded |
| k2_prime_prime = 1. rate = k2_prime_prime * Cdc20 * CycB Using MM: rate = kcat * Cdc20 * CycB / (CycB + Km) Let Km >> CycB, ie, around 100. Then kcat = k2_prime_prime * Km = 100. | ||||||||
| 2 | Cdc20 / Cdc20_deg_CycA | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 10 | 200 | 4 | explicit E-S complex | Substrate CycA Product degraded |
| Rate comes in as k30 = 20 Rate = [Cdc20]*[CycA] * k30. To put in MM form: Rate = [Cdc20]*[CycA] * kcat / (Km + [CycA]) where kcat = k30 * Km and Km >> [CycA]. Put Km = 1000, so kcat = 20000 25 March: use explicit enz form. Use rate = k3*k1/k2 = 20, which works if k2 >> k3. Then let k3 = 1, k2 = 10, k1 becomes 200 7 Apr 2005: Above won't work because of low Km consuming too much of the Cdc20 in the complex form. So use Km = 10, kcat = 200. | ||||||||
| 3 | Cdc20 / Kip1 | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 10 | 200 | 4 | explicit E-S complex | Substrate CycA_Kip1 Product Kip1 degraded |
| Rate comes in as k30 = 20 Same rate as for CycA alone. Rate = [Cdc20]*[CycA_Kip1] * k30. To put in MM form: Rate = [Cdc20]*[CycA_Kip1] * kcat / (Km + [CycA_Kip1]) where kcat = k30 * Km and Km >> [CycA_Kip1]. Put Km = 1000, so kcat = 20000 Similar to CycA alone, we instead get k2 = 10, k3 = 1, so k1 = 200. 19 Apr 2005: Go back to MM form because of low Km. Let Km = 10, then kcat = Km * k30 = 200. | ||||||||
| 4 | Cdc20 / Cdh1_Cdc20 | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 0.0100001 | 140 | 4 | explicit E-S complex | Substrate Cdh1_i Product Cdh1 |
| k3 = 140 Km = j3 = 0.01 | ||||||||
Cdc20 acting as a Substrate for an Enzyme in Mammalian_cell_cycle Network
| Enzyme Molecule / Enzyme Activity | Accession Name | Pathway Name | Km (uM) | kcat (s^-1) | Ratio | Enzyme Type | Reagents |
| k14_enz / k14 | cycle Accession No. : 85 | Cdc20_Grp Pathway No. : 1074 | 0.00500008 | 2.5 | 4 | explicit E-S complex | Substrate Cdc20 Product Cdc20notA |
| Represented as k14.[Cdc20] / (J4 + [Cdc20]) But I suspect it should be J14. k14 = 2.5 J14 = 0.005 If we set enz = 1, Km = J14, kcat = k14, this equation applies. | |||||||
Cdc20 acting as a Product of an Enzyme in Mammalian_cell_cycle Network
| Enzyme Molecule / Enzyme Activity | Accession Name | Pathway Name | Km (uM) | kcat (s^-1) | Ratio | Enzyme Type | Reagents |
| IEP / k13 | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 0.00499996 | 5 | 4 | explicit E-S complex | Substrate Cdc20notA Product Cdc20 |
| Represented as k13.[IEP].[Cdc20A]/(J13 + [Cdc20A]) which is a classical MM form. k13 = 5, J13 = 0.005 | |||||||
Cdc20 acting as a Substrate in a reaction in Mammalian_cell_cycle Network
| Kd is calculated only for second order reactions, like nA+nB <->nC or nA<->nC+nD, where n is number and A,B,C,D are molecules, where as for first order reactions Keq is calculated. Kd for higher order reaction are not consider. |
| Name | Accession Name | Pathway Name | Kf | Kb | Kd | tau | Reagents |
| k12 | cycle Accession No. : 85 | Cdc20_Grp Pathway No. : 1074 | 1.5 (s^-1) | 0 (s^-1) | - | - | Substrate Cdc20 Product degraded |
color.